Evidence map›Paper›PMID 23587449›Full record

ArticleEpidemiology and infection2014

Seroepidemiology of Toxoplasma gondii infection in the Israeli population.

M Perry Markovich, T Shohat, I Riklis, R Avni, D Yujelevski-Rozenblit, R Bassal, D Cohen, E Rorman

Open access · greenAbstract read
In one paragraph

Article in Epidemiology and infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. The Israel National Sera Bank: Methods, Representativeness, and Challenges.International journal of environmental research and public health · 2021
    Article
  3. High Exposure toAnimals : an open access journal from MDPI · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. Seroepidemiology ofJournal of clinical medicine research · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

M Perry MarkovichIsrael Center for Diseases Control, Israel Ministry of Health, Tel-Hashomer, Israel.
T Shohat
I Riklis
R Avni
D Yujelevski-Rozenblit
R Bassal
D Cohen
E Rorman
Israel Ministry of Health · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasmosis seroprevalence varies considerably between countries. We studied the seroprevalence of Toxoplasma gondii IgG antibodies in a national sample of the Israeli population; 2794 sera were tested. The highest age-adjusted seroprevalence rate was in Arabs (non-Bedouins) (60.4%), significantly higher compared to the rate in Jews (19.9%) and Bedouins (27.5%) (P < 0.01). There were no significant gender differences. Seropositivity increased with age in all population groups. For Jews, seropositivity was associated with place of birth and socioeconomic status. A finding of low seroprevalence rate in Bedouins despite their poor living conditions and close contact with livestock is surprising, and might be attributed to the dry and hot climate conditions in their area of residence. In women of reproductive age the seroprevalence was 15.1% in Jews, 25.4% in Bedouins and 72.3% in Arabs (non-Bedouins). Thus, the majority of pregnant women are susceptible to primary infection with T. gondii, and the risk for congenital toxoplasmosis remains high.

Indexed as

AdolescentAdultAgedAntibodies, ProtozoanArabsChildChild, PreschoolChi-Square DistributionCross-Sectional StudiesFemaleHumansImmunoglobulin GInfantIsraelJewsMaleAntibodies, ProtozoanImmunoglobulin G

Identifiers

PMID23587449
PMCPMC9152547
OpenAlexW2093714526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.